FDA panel hears from dissatisfied LASIK patients

The US Food and Drug Administration (FDA) has convened a special panel to hear from patients following concerns about patient satisfaction with LASIK. The meeting discussed the experiences of patients who had suffered complications from the procedure. The FDA had received 140 complaints of side-effects and device malfunctions between 1998 and 2006 and said it was seeking advice over information currently available to patients considering or undergoing the procedure and whether changes should be made. The agency also confirmed it would conduct a study with the National Eye Institute and other bodies to assess the quality of life of patients after LASIK surgery